Implications and consequences of enzyme induction on preclinical and clinical drug development

References

• AMACHER, D. E., SCHOMAKER, S. J. and BURKHARDT, J. E., 1998, The relationship among microsomal enzyme induction, liver weight and histological change in rat toxicology studies. Food and Chemical Toxicology, 36, 831–839.
   PubMed Web of Science ®Google Scholar
• ANDERSSON, T., CEDERBERG, C., EDVARDSSON, G., HEGGELUND, A. and LUNDBORG, P., 1990, Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Clinical Pharmacology and Therapeutics, 47, 79–85.
   PubMed Web of Science ®Google Scholar
• BACKMAN, J. T., OLKKOLA, K. T., LAAKSOVIRTA, H. and NEUVONEN, P. J., 1996, Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbemazepine or phenytoin. Epi/epsia, 37, 253–257.
   PubMed Web of Science ®Google Scholar
• BARDITCH-CROVO, P., TRAPNELL, C. B., ETTE, E., ZACUR, H. A., CORESH, J., Rocco, L. E., HENDRIX, C. W. and FLEXNER, C., 1999, The effects of rifampicin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Clinical Pharmacology and Therapeutics, 65, 428–438.
   Google Scholar
• BARS, R. G., MITCHELL, A. M., WOLF, C. R. and ELCOMBE, C. R., 1989, Induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localization of specific isoenzymes using immunocytochemistry. Biochemical Journal, 262, 151–158.
   PubMed Web of Science ®Google Scholar
• BARWICK, J. L., QUATTROCHI, L. C., MILLS, A. S., POTENZA, C., TUKEY, R. H. and GUZELIAN, P. S., 1996, Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Molecular Pharmacology, 50, 1 0–16.
   Google Scholar
• BOCK, K. W., LIPP, H. P. and BOCK-HENNIG, B. S., 1990, Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica, 20, 1101–1111.
   Google Scholar
• BOWEN, W. P., CAREY, J. E., MIAH, A., MCMURRAY, H. F., MUNDAY, P. W., JAMES, R. S., COLEMAN, R. A. and BROWN, A. M., 2000, Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymeraw chain reaction. Drug Metabolism and Disposition, 28, 781–788.
   PubMed Web of Science ®Google Scholar
• CATTLEY, R. C., DELUCA, J., ELCOMBE, C., FENNER-CRISP, P., LAKE, B. G., MARSMAN, D. S., PASTOOR, T. A., Popp, J. A., ROBINSON, D. E., SCHWETZ, B., TUGWOOD, J. and WAin,i, W., 1998, Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regulatory Toxicology and Pharmacology, 27, 47–60.
   Google Scholar
• CRESPI, C. L., MILLER, V. P. and PENMAN, B. W., 1998, High throughput screening for inhibition of cytochrome P450 metabolism. Medicinal Chemistry Research, 8, 457–471.
   Web of Science ®Google Scholar
• CURI -PEDROSA, R., DAUJAT, M., PICHARD, L., OURLIN, J. C., CLAIR, P., GERVOT, L., LESCA, P., DOMERGUE, J., JoyEux, H., FOURTANIER, G. and MAUREL, P., 1994, Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture. Journal of Pharmacology and Experimental Therapeutics, 269, 384–392.
   Google Scholar
• CZERWINSKI, M., MCLEMORE, T. L., GELBOIN, H. V. and GONZALEZ, F. J., 1994, Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Research, 54, 1085-1 091.
   Google Scholar
• DONATO, M. T., CASTELL, J. V. and GOMEZ-LECHON, M. J., 1995, Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metabolism and Disposition, 23, 553–558.
   Google Scholar
• EKINS, S., MURRAY, G. I., BURKE, M. D., WILLIAMS, J. A., MARCHANT, N. C. and HAWKSWORTH, G. M., 1995, Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug Metabolism and Disposition, 23, 1274-1 279.
   PubMed Web of Science ®Google Scholar
• FAVREAU, L. V., PALAMANDA, J. R., LIN, C.-C. and NOMEIR, A. A., 1999, Improved reliability of the rapid microtitre plate assay using recombinant enzyme in predicting CYP2D6 inhibition in human liver microsomes. Drug Metabolism and Disposition, 27, 436–439.
   Google Scholar
• GLUE, P., BANELD, C. R., PERHACH, J. L., MATHER, G. G., RACHA, J. K. and LEVY, R. H., 1997, Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. Clinical Pharmacokinetics, 33, 214–224.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LECHON, M. J., JovER, R., DONATO, T., PONSODA, X., RODRIGUEZ, C., STENZEL, K. G., KLOCKE, R., PAUL, D., GUILLEN, I., BORT, R. and CASTELL, J. V., 1998, Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix. Journal of Cell Physiology, 177, 553–562.
   Google Scholar
• GONZALEZ, F. J., CRESPI, C. L., CZERWINSKI, M. and GELBOIN, H. V., 1992, Analysis of human cytochrome P450 catalytic activities and expression. Tohoku Journal of Experimental Medicine, 168, 67–72.
   PubMed Web of Science ®Google Scholar
• GORSKI, J. C., HALL, S. D., JoNEs, D. R., VANDEN-BRANDEN, M. and WRIGHTON, S. A., 1994, Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochemical Pharmacology, 47, 1643–1653.
   Google Scholar
• HEIMARK, L. D., GIBALDI, M., TRAGER, W. F., O'REILLY, R. A. and GOULART, D. A., 1987, The mechanism of the warfarin-rifampin drug interaction in humans. Clinical Pharmacology and Therapeutics, 42, 388–394.
   Google Scholar
• HOUSTON, J. B. and CAROLE, D. J., 1997, Prediction of hepatic clearance from microsomes, hepatocytes and liver slices. Drug Metabolism Reviews, 29, 891–922.
   PubMed Web of Science ®Google Scholar
• HOUSTON, J. B. and KENWORTHY, K. E., 2000, In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metabolism and Disposition, 28, 246–254.
   PubMed Web of Science ®Google Scholar
• KOKUFU, T., IHARA, N., SUGIOKA, N., KOYAMA, H., OHTA, T., MORI, S. and NAKAJIMA, K., 1995, Effects of lansoprazole on pharmacokinetics and metabolism of theophylline. European Journal of Clinical Pharmacology, 48, 391–395.
   PubMed Web of Science ®Google Scholar
• LAVE, T., DUPIN, S., Scumirr, C., Cuou, R. C., JAECK, D. and COASSOLO, P., 1997, Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. Journal of Pharmaceutical Sciences, 86, 246–254.
   Google Scholar
• LECLUYSE, E. L., BULLOCK, P. L. and PARKINSON, A., 1996, Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes. Advances in Drug Delivery Reviews, 22, 133–186.
   Web of Science ®Google Scholar
• LI, A. P., GORYCKI, P. D., HENGSTLER, J. G., KEDDERIS, G. L., KOEBE, H. G., RAHMANI, R., DE SOUSAS, G., SILVA, J. M. and SKETT, P., 1999, Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. Chemko-Biological Interactions, 121, 117–123.
   PubMed Web of Science ®Google Scholar
• LI, A. P., MAUREL, P., GOMEZ-LECHON, M. J., CHENG, L. C. and JuKuLA-RomEY, M., 1997b, Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. Chemico-Biological Interactions, 107, 5–16.
   Google Scholar
• LI, A. P., REITH, M. K., RASMUSSEN, A., GORSKI, J. C., HALL, S., D., XU, L., KAMINSKI, D. L. and CHENG, L. K., 1997a, Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin. Chemico -BiologicalInteractions, 107, 17–30.
   Google Scholar
• LOL, C. M., STERN, R., KOUP, J. R., Vassos, A. B., KNOWLTON, P. and SEDMAN, A. J., 1999, Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent. Journal of Clinical Pharmacology, 39, 410–417.
   PubMedGoogle Scholar
• LUCAS, R. A., GILLLAN, D. J. and BERGSTROM, R. F., 1998, A pharmacokinetic interaction between carbemazepine and olanzapine: observations on possible mechanism. European Journal of Clinical Pharmacology, 54, 639–643.
   PubMed Web of Science ®Google Scholar
• MADAN, A., PARKINSON, A. and FAIMAN, M. D., 1998, Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfirarn bioactivation. Alcohol: Clinical and Experimental Research, 22, 1212–1219.
   PubMed Web of Science ®Google Scholar
• MEUNIER, V., BOURRIE, M., JULIAN, B., MARTI, E., GUILLOU, F., BERGER, Y. and FABRE, G., 2000, Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up. Xenobiotica, 30, 589–607.
   PubMed Web of Science ®Google Scholar
• NGUYEN, L. T., RAMANATHAN, M., WEINSTOCK-GUTTMAN, B., DOLE, K., MILLER, C., PLANTER, M., PATRICK, K., BROWNSCHEIDLE, C. and JAcoas, L., D., 2000, Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays. Drug Metabolism and Disposition, 28, 987–993.
   Google Scholar
• NICOLL-GRITH, D. A., SILVA, J. M., CHAURET, N., DAY, S., LEBLANC, Y., ROY, P., YERGEY, J. A., DIXIT, R. and PATRICK, D., 2001, Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: studies with DFP, a cyclooxygenase-2 inhibitor. Drug Metabolism and Disposition, 29, 159–165.
   Google Scholar
• OGG, M. S., WILLiAms, J. M., TARBIT, M., GOLDFARB, P. S., GRAY, T. J. B. and GIBSON, G. G., 1999, A reporter gene assay to assess the molecular mechanisms of xenobiotic- dependent induction of the human CYP3A4 gene in vitro. Xenobiotica, 29, 269–279.
   Google Scholar
• OKEY, A. B., 1990, Enzyme induction in the cytochrome P-450 system. Pharmacology and Therapeutics, 45, 241–298.
   PubMed Web of Science ®Google Scholar
• PADGHAM, C. R., BOYLE, C. C., WANG, X. J., RALEIGH, S. M., WRIGHT, M. C. and PAINE, A. J., 1993, Alteration of transcription factor mRNAs during the isolation and culture of rat hepatocytes suggests the activation of a proliferative mode underlies their de-differentiation. Biochemical and Biophysical Research, 197, 599–605.
   PubMed Web of Science ®Google Scholar
• PADGHAM, C. R. W. and PAINE, A. J., 1993, Altered expression of cytochrome P-450 mRNAs, and potentially of other transcripts encoding key hepatic functions, are triggered during the isolation of rat hepatocytes. Biochemical Journal, 289, 621–624.
   Google Scholar
• PAINE, A. J., 1990, The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system. Chemico -BiologicalInteractions, 74, 1–31.
   PubMed Web of Science ®Google Scholar
• PAN, J., XIANG, Q. and BALL, S., 2000, Use of a novel real-time quantitative reverse transcription-polymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver. Drug Metabolism and Disposition, 28, 709–713.
   PubMed Web of Science ®Google Scholar
• PANG, K. S. and ROWLAND, M., 1977, Hepatic clearance of drugs. I. Theoretical considerations of a 'well stirred' and a 'parallel tube' model: influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. Journal of Pharmacokinetics and Biopharmaceutks, 5, 625–653.
   PubMedGoogle Scholar
• PARK, B. K., KITTERINGHAM, N. R., PIRMOHAMED, M. and TUCKER, G. T., 1996, Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications. British Journal of Clinical Pharmacology, 41, 477–491.
   PubMed Web of Science ®Google Scholar
• PATSALOS, P. N. and DUNCAN, J. S., 1993, Antiepileptic drugs. A review of clinically significant drug interactions. Drug Safety, 9, 156–184.
   PubMedGoogle Scholar
• PICHARD-GARCIA, L., HYLAND, R., BAULIEU, J., FABRE, J. M., MILTON, A. and MAUREL, P., 2000, Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by elitriptan in vivo. Drug Metabolism and Disposition, 28, 51–57.
   Google Scholar
• PRICE, R. J., BALL, S. E., RENWICK, A. B., BARTON, P. T., BEAMAND, A. and LAKE, B. G., 1998, Use of precision-cut rat liver slices for studies of xenobiotic metabolism and toxicity: comparison of the Krumdieck and Brendel tissue slicers. Xenobiotica, 28, 361–371.
   PubMed Web of Science ®Google Scholar
• RIVA, R., ÄLBANI, F., CONTIN, M. and BARUZZI, A., 1996, Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clinical Pharmacokinetics, 31, 470–493.
   Google Scholar
• ROMANKIEWICZ, J. A. and EHRMAN, M., 1975, Rifampin and warfarin: a drug interaction. Annals of Internal Medicine, 82, 224–225.
   PubMed Web of Science ®Google Scholar
• RYU, D. Y., LEVI, P. E., FERNANDEZ-SALGUERO, P., GONZALEZ, F. J. and HODGSON, E., 1996, Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver. Molecular Pharmacology, 50, 443–446.
   Google Scholar
• SAHI, J., HAMILTON, G., SINZ, M., BARROS, S., HUANG, S. M., LESKO, L. J. and LECLUYSE, E. L., 2000, Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes. Drug Metabolism and Disposition, 30, 273–284.
   Google Scholar
• SCHUETZ, J. D., BEACH, D. L. and GUZELIAN, P. S., 1994, Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics, 4, 11–20.
   PubMedGoogle Scholar
• SHARER, J. E., SHIPLEY, L. A., VANDENBRANDEN, M. R., BINKLEY, S. N. and WRIGHTON, S. A., 1995, Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition, 23, 1231–1241.
   PubMed Web of Science ®Google Scholar
• SMITH, D. A., 2000, Induction and drug development. European journal of Pharmaceutical Sciences, 11, 185–189.
   PubMed Web of Science ®Google Scholar
• SOMOGYI, A., THIELSCHER, S. and GUGLE R., 1981, Influence of phenobarbital treatment on cimetidine kinetics. European Journal of Clinical Pharmacology, 19, 343–347.
   PubMedGoogle Scholar
• STENBERG, P., LUTHMAN, K. and ÄRTURSSON, P., 2000, Virtual screening of intestinal drug permeability. Journal of Controlled Release, 65, 231–243.
   Google Scholar
• STROM, S. C., PISAROV, L. A., DORKO, K., THOMPSON, M. T., SCHUETZ, J. D., SCHUETZ, E. G., 1996, Use of human hepatocytes to study P450 gene induction. Methods in Enzymology, 272, 388–401.
   PubMed Web of Science ®Google Scholar
• SURRY, D. D., McALLisma, G., MENESES-LORENTE, G. and EVANS, D. C., 1999, High throughput ribonuclease protection assay for the determination of CYP3A mRNA induction in cultured rat hepatocytes. Xenobiotica, 29, 827–838.
   Google Scholar
• SURRY, D. D., MENESES-LORENTE, G., HEAVENS, R., JACK, A. and EVANS, D. C., 2000, Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1. Xenobiotica, 30, 441–456.
   Google Scholar
• TUCKER, G. T., 2000, Pharmacokinetic and pharmacodynamic implications of pharmacogenetics. Drug Metabolism Reviews, 32 (suppl. 1), 8.
   Google Scholar
• VAN HAL, N. L., VORST, O., VAN HOUWELINGEN, A. M., KOK, E. J., PEIJNENBURG, A., AHARONI, A., VAN TUNEN, A. J. and KEIJER, J., 2000, The application of DNA microarrays in gene expression analysis. Journal of Biotechnology, 78, 271–280.
   PubMedGoogle Scholar
• VARLEY, C. L. and DICKSON, A. J., 1999, Hepatocyte isolation stimulates formation of interferon stimulatory response element DNA—protein complexes. Biochemical and Biophysical Research Communications, 263, 627–631.
   PubMedGoogle Scholar
• VENKATAKRISHNAN, K., VON MOLTKE, L. L., COURT, M. H., HARMATZ, J. S., CRESPI, C. L. and GREENBLATT, D. J., 2000, Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches. Drug Metabolism and Disposition, 28, 1493–1504.
   PubMed Web of Science ®Google Scholar
• VILLIKKA, K., KIVISTO, K. T. and NEUVONEN, P. J., 1998, The effect of dexamethasone on the pharmacokinetics of triazolam. Pharmacology and Toxicology, 83, 135–138.
   PubMedGoogle Scholar
• WANG, R. W., NEWTON, D. J., Liu, N. Y., Snou, M., RUSHMORE, T. and Lu, A. Y. H., 1999, Inhibitory anti-CYP3A4 peptide antibody: mapping of inhibitory epitope and specificity toward other CYP3A isoforms. Drug Metabolism and Disposition, 27, 167–172.
   PubMedGoogle Scholar
• WORBOYS, P. D., BRADBURY, A. and HOUSTON, J. B., 1997, Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate. Drug Metabolism and Disposition, 25, 460–467.
   PubMed Web of Science ®Google Scholar
• WORTELBOER, H. M., DE KRUIF, C. A., VAN TEASEL, A. A. J., FALKE, H. E., NOORDHOEK, J., BLAAUBOER, B. J., 1991, Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Biochemical Pharmacology, 42, 381–390.
   Google Scholar
• WRIGHT, M. C., PAINE, A. J., SKETT, P. and AULD, R., 1994, Induction of rat hepatic glucocorticoid-inducible cytochrome P450 3A by metyrapone. Journal of Steroid Biochemistry and Molecular Biology, 48, 271–276.
   PubMed Web of Science ®Google Scholar
• XIE, W., BARWICK, J. L., DOWNES, M., BLUMBERG, B., SIMON, C. M., NELSON, M. C., NEUSCHWANDER-TETRI, B. A., BRUNT, E. M., GUZELIAN, P. S. and EVANS, R. M., 2000, Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature, 406, 435–439.
   Google Scholar
• YEE, S., 1997, In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinate) absorption in man — fact or myth. Pharmaceutical Research, 14, 763–766.
   PubMed Web of Science ®Google Scholar
• YOUNG, R. A., 2000, Biomedical discovery with DNA arrays. Cell, 102, 9–15.
   PubMed Web of Science ®Google Scholar